Document Type
Article
Publication Date
2018
College/Unit
School of Medicine
Department/Program/Center
Exercise Physiology
Abstract
Background: The integration of engineered nanomaterials (ENM) is well-established and widespread in clinical, commercial, and domestic applications. Cardiovascular dysfunctions have been reported in adult populations after exposure to a variety of ENM. As the diversity of these exposures continues to increase, the fetal ramifications of maternal exposures have yet to be determined. We, and others, have explored the consequences of ENM inhalation during gestation and identified many cardiovascular and metabolic outcomes in the F1 generation. The purpose of these studies was to identify genetic alterations in the F1 generation of Sprague-Dawley rats that result from maternal ENM inhalation during gestation. Pregnant dams were exposed to nano-titanium dioxide (nano-TiO2) aerosols (10 ± 0. 5 mg/m3) for 7-8 days (calculated, cumulative lung deposition = 217 ± 1 μg) and on GD (gestational day) 20 fetal hearts were isolated. DNA was extracted and immunoprecipitated with modified chromatin marks histone 3 lysine 4 tri-methylation (H3K4me3) and histone 3 lysine 27 tri-methylation (H3K27me3). Following chromatin immunoprecipitation (ChIP), DNA fragments were sequenced. RNA from fetal hearts was purified and prepared for RNA sequencing and transcriptomic analysis. Ingenuity Pathway Analysis (IPA) was then used to identify pathways most modified by gestational ENM exposure.
Results: The results of the sequencing experiments provide initial evidence that significant epigenetic and transcriptomic changes occur in the cardiac tissue of maternal nano-TiO2 exposed progeny. The most notable alterations in major biologic systems included immune adaptation and organismal growth. Changes in normal physiology were linked with other tissues, including liver and kidneys.
Conclusions: These results are the first evidence that maternal ENM inhalation impacts the fetal epigenome.
Digital Commons Citation
Stapleton, P.A.; Hathaway, Q.A.; Nichols, C.E.; Abukabda, A.B.; Pinti, M.V.; Shepherd, D.L.; McBride, C.R.; Yi, J.; Castranova, V.C.; Hollander, J.M; and Nurkiewicz, Timothy Robert, "Maternal engineered nanomaterial inhalation during gestation alters the fetal transcriptome" (2018). Faculty & Staff Scholarship. 1851.
https://researchrepository.wvu.edu/faculty_publications/1851
Source Citation
Stapleton, P. A., Hathaway, Q. A., Nichols, C. E., Abukabda, A. B., Pinti, M. V., Shepherd, D. L., McBride, C. R., Yi, J., Castranova, V. C., Hollander, J. M., & Nurkiewicz, T. R. (2018). Maternal engineered nanomaterial inhalation during gestation alters the fetal transcriptome. Particle and Fibre Toxicology, 15(1). https://doi.org/10.1186/s12989-017-0239-8
Included in
Diseases Commons, Environmental Health Commons, Exercise Physiology Commons, Immunology and Infectious Disease Commons, Medical Pharmacology Commons, Medical Toxicology Commons, Neuroscience and Neurobiology Commons, Pharmacy and Pharmaceutical Sciences Commons
Comments
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.